Correlation Between Dermata Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Dermata Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Revelation Biosciences.
Diversification Opportunities for Dermata Therapeutics and Revelation Biosciences
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Dermata and Revelation is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Dermata Therapeutics is expected to generate 1.57 times more return on investment than Revelation Biosciences. However, Dermata Therapeutics is 1.57 times more volatile than Revelation Biosciences. It trades about -0.03 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.07 per unit of risk. If you would invest 160.00 in Dermata Therapeutics on September 2, 2024 and sell it today you would lose (47.00) from holding Dermata Therapeutics or give up 29.38% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Dermata Therapeutics vs. Revelation Biosciences
Performance |
Timeline |
Dermata Therapeutics |
Revelation Biosciences |
Dermata Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dermata Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Dermata Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |